Ifp Advisors, Inc X4 Pharmaceuticals, Inc Transaction History

Ifp Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 12, 2022	SELL	$1.9 - $5.6 $1,900 - $5,600	-1,000 Closed	0 $0
Q3 2021 Oct 06, 2021	BUY	$4.53 - $6.45 $4,530 - $6,450	1,000 New	1,000 $5,000
Q2 2021 Jul 13, 2021	BUY	$6.49 - $9.56 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$6.63 - $10.28 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$5.41 - $7.4 $0 - $0	0 New	0 $0

106

103M

206K

291K

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $39.8M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.